Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor.

Stolarov J, Chang K, Reiner A, Rodgers L, Hannon GJ, Wigler MH, Mittal V.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13043-8. Epub 2001 Oct 30.

2.

PTEN controls tumor-induced angiogenesis.

Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK, Durden DL.

Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4622-7. Epub 2001 Mar 27.

3.

The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13513-8.

4.

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052-7.

5.

Programmed cell death in the absence of c-Fos and c-Jun.

Roffler-Tarlov S, Brown JJ, Tarlov E, Stolarov J, Chapman DL, Alexiou M, Papaioannou VE.

Development. 1996 Jan;122(1):1-9.

Supplemental Content

Loading ...
Support Center